BR112022007740A2 - Dispositivo aplicador e métodos de uso - Google Patents

Dispositivo aplicador e métodos de uso

Info

Publication number
BR112022007740A2
BR112022007740A2 BR112022007740A BR112022007740A BR112022007740A2 BR 112022007740 A2 BR112022007740 A2 BR 112022007740A2 BR 112022007740 A BR112022007740 A BR 112022007740A BR 112022007740 A BR112022007740 A BR 112022007740A BR 112022007740 A2 BR112022007740 A2 BR 112022007740A2
Authority
BR
Brazil
Prior art keywords
methods
applicator device
applicator
micropore
administering
Prior art date
Application number
BR112022007740A
Other languages
English (en)
Inventor
Hopkins Janine
Original Assignee
Hopkins Janine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hopkins Janine filed Critical Hopkins Janine
Publication of BR112022007740A2 publication Critical patent/BR112022007740A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0415—Plasma
    • A61M2202/0423—Serum; Human serous fluid, i.e. plasma without fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0427—Platelets; Thrombocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A61M2202/0445—Proteins
    • A61M2202/0447—Glycoproteins
    • A61M2202/045—Fibrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/27—General characteristics of the apparatus preventing use
    • A61M2205/273—General characteristics of the apparatus preventing use preventing reuse, e.g. of disposables
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/04—Skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A presente invenção se refere a um aplicador, configurado para se ligar de maneira reversível a um dispositivo de dispensação, com pelo menos um microporo e um kit para administração de um agente terapêutico. Os métodos de uso do aplicador também são divulgados no presente documento.
BR112022007740A 2019-10-24 2020-10-23 Dispositivo aplicador e métodos de uso BR112022007740A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962925527P 2019-10-24 2019-10-24
PCT/US2020/057151 WO2021081392A1 (en) 2019-10-24 2020-10-23 Applicator device and methods of use

Publications (1)

Publication Number Publication Date
BR112022007740A2 true BR112022007740A2 (pt) 2022-07-12

Family

ID=75620350

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022007740A BR112022007740A2 (pt) 2019-10-24 2020-10-23 Dispositivo aplicador e métodos de uso

Country Status (7)

Country Link
US (1) US20220362532A1 (pt)
EP (1) EP4048366A4 (pt)
JP (1) JP2022554188A (pt)
KR (1) KR20220097412A (pt)
CN (1) CN114728153A (pt)
BR (1) BR112022007740A2 (pt)
WO (1) WO2021081392A1 (pt)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925327A (en) * 1985-11-18 1990-05-15 Minnesota Mining And Manufacturing Company Liquid applicator with metering insert
FR2744104B1 (fr) * 1996-01-29 1998-03-20 Oreal Dispositif de conditionnement, de distribution et d'application d'un gel ou mousse
US6623457B1 (en) * 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US6528086B2 (en) * 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6537242B1 (en) * 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
CH695412A5 (it) * 2004-10-19 2006-05-15 Labo Cosprophar Ag Metodo e kit particolarmente per applicare un prodotto cosmetico.
DE102007022255B4 (de) * 2007-05-09 2009-07-09 Beiersdorf Ag Ausgabeöffnungsplatte für optisch attraktive Antitranspirant Formulierungen
US8840331B2 (en) * 2008-05-26 2014-09-23 Novartis Ag Kit for topical application of medication
BRPI1011316B8 (pt) * 2009-05-26 2021-06-22 Massachusetts Gen Hospital aparelho para administrar uma substância ao tecido da pele
WO2011083427A2 (en) * 2010-01-06 2011-07-14 L'oreal A packaging and applicator device including an applicator member
JP2017537690A (ja) * 2014-11-12 2017-12-21 ミューファーマ ピーティーワイ リミテッド 非侵襲性の薬剤塗布具
US10524835B2 (en) * 2017-04-25 2020-01-07 John H. Shadduck Fluid skin treatment systems and methods
CN208049192U (zh) * 2017-07-26 2018-11-06 沈伟 一种医用涂抹器的涂抹头
US10434294B2 (en) * 2017-11-17 2019-10-08 Esthetic Education LLC Sterile applicator assembly with microneedle array
CN107715290A (zh) * 2017-11-22 2018-02-23 成都名典匠心工业产品设计有限公司 一种皮肤科用药膏涂抹装置
CN208464945U (zh) * 2018-01-18 2019-02-05 广州丝毕丽生物科技有限公司 一种高效点触式美容器
CN209137732U (zh) * 2018-04-24 2019-07-23 严晓燕 一种皮肤科用药膏涂抹装置
CN108815693B (zh) * 2018-05-09 2021-03-12 青岛大学附属医院 一种妇科的外用药剂的施药装置

Also Published As

Publication number Publication date
EP4048366A4 (en) 2024-01-03
WO2021081392A1 (en) 2021-04-29
EP4048366A1 (en) 2022-08-31
KR20220097412A (ko) 2022-07-07
JP2022554188A (ja) 2022-12-28
US20220362532A1 (en) 2022-11-17
CN114728153A (zh) 2022-07-08

Similar Documents

Publication Publication Date Title
DOP2020000021A (es) Anticuerpos anti-cd39, composiciones que comprenden anticuerpos anti-cd39, y métodos de uso de anticuerpos anti-cd39
DOP2019000180A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
CL2017003436A1 (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso
BR112019018863A8 (pt) Tcrs de alta afinidade específicos para mage-a1 e usos dos mesmos
BR112019022495A2 (pt) Conjugados de anticorpo que compreendem agonista de receptor similar a toll e terapias de combinação
DOP2018000297A (es) Derivado de glucagon, conjugado del mismo, composición que comprende el mismo y uso terapéutico del mismo
BR112015026006A2 (pt) métodos para o tratamento de câncer com o uso de terapia de combinação com inibidor de cinase tor
BR112015025711A8 (pt) uso de ibrutinibe e coposição farmacêutica compreendendo ibrutinibe e um agente anticâncer
BR112016026993A2 (pt) combinação de um anticorpo anti-ccr4 e um agonista 4-1bb para tratar câncer
CO7350624A2 (es) Inhibidores de la tirosina-quinasa de bruton
BR112016004415A2 (pt) método de tratamento de um paciente diagnosticado com um glioblastoma, uso de uma quantidade eficaz de um anticorpo anti-vegf, composição e kit
BR112017023576A2 (pt) Método para tratar uma disfunção proliferativa de células b
CL2008001268A1 (es) Compuestos derivados de n-[6-amino-5-aril-piridin-2-il]-carboxamida; composicion farmaceutica que los comprende; composicion farmaceutica combinada que los comprende junto a otro agente farmacologico adicional; y uso de los mismos en el tratamiento del dolor.
BR112015020911A2 (pt) anticorpo, uso de uma combinação e método de tratamento
AR108021A1 (es) Conjugados de anticuerpo-principio activo (adcs) de inhibidores de ksp con anticuerpos anti-b7h3
CL2011003160A1 (es) Compuestos derivados de heterociclicos, moduladores cb2; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades reumaticas, autoinmune, inflamatorias, dolor, entre otras.
BR112015030356A2 (pt) métodos de tratamento de uma taupatia
BR112015030385A8 (pt) composto, composto para uso e composição farmacêutica
BR112015026247A8 (pt) composto em combinação com um análogo de citidina, composição farmacêutica que os compreende, uso dos mesmos e kit
CL2017002214A1 (es) Formulación de combinación de tesofensina y betabloqueante
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
BR112016001544A2 (pt) composições farmacêuticas para injeção intraocular compreendendo agentes anti-bacteriano e anti-inflamatório, seu método de preparação, kit farmacêutico e uso dos referidos agentes no preparo das referidas composições farmacêuticas
MX2022005132A (es) Terapia combinada con formulaciones de anticuerpos anti-pvrig y anticuerpos anti-pd-1.
BR112012022243A8 (pt) Uso de um inibidor de autofagia baseado em tioxantona e de um composto indutor de autofagia para terapia de câncer, composição farmacêutica e kit farmacêutico
BR112022012205A2 (pt) Compostos ativos para receptores nucleares